| Line Item | 2022-07-01 | Y/Y |
|---|---|---|
| Revenue | $303.0M | +10.2% |
| Cost of Revenue | $193.7M | +12.4% |
| Gross Profit | $109.2M | +6.5% |
| R&D Expense | $22.6M | +3.6% |
| SG&A Expense | $57.7M | +2.4% |
| Operating Income | $28.7M | +29.4% |
| Pre-tax Income | $30.4M | +35.6% |
| Income Tax | $9.3M | +110.6% |
| Net Income | $21.2M |
| Line Item | 2022-07-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.9M | -23.1% |
| Short-term Investments | $10.9M | — |
| Accounts Receivable | $73.2M | +52.0% |
| Current Assets | $206.4M | +21.2% |
| Total Assets | $323.9M | +8.8% |
| Current Liabilities | $104.5M | +8.4% |
| Total Liabilities | $122.2M | +6.9% |
| Line Item | 2022-07-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.8M | -83.9% |
| Capital Expenditures | $1.8M | -37.1% |
| Investing Cash Flow | -$7.8M | -173.5% |
| Financing Cash Flow | -$4.9M | +39.4% |
| Free Cash Flow | $997K | -93.1% |
| -80.8% |
| EPS (Basic) | $1.89 | -81.1% |
| EPS (Diluted) | $1.79 | -81.0% |
| Stockholders' Equity |
| $201.8M |
| +10.0% |